Approved for Long-term maintenance treatment of airflow obstruction in patients with COPD. Combines umeclidinium (LAMA) and vilanterol (LABA) to provide dual bronchodilation. Umeclidinium blocks M3 receptors while vilanterol stimulates beta-2 receptors, producing complementary… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and…
Loading full data from Know Your Drugs Institute…